Wu XN. Current concept of pathogenesis of severe acute pancreatitis. World J Gastroenterol 2000; 6(1): 32-36
Corresponding Author of This Article
Dr. Xie-Ning Wu, Department of Gastroenterol ogy and Central Research Laboratory, Shanghai First People’s Hospital, No.85, Wujing Road, Shanghai 200080, China
Article-Type of This Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
The pathogenesis of severe acute pancreatitis is very complicated. It is a multifactorial as well as multifaceted disease. First of all, the etiologic agents in itiate the pancreatic acinar injury by release of pancreatic enzymes and overstimulation of macrophages and neutrophils, then the cytokines and inflammatory mediators are liberated. There is also interaction between neutrophils and endothelial cells producing free radicals, the cytokines cause increasing vascular permeability, activating complement component, resulting in microcirculatory impairment and imbalance of thrombo-fibrinolytic system. Many of these events occur not only in the pancreas itself, but also in the other vital organs and tissues, leading to severe acute pancreatitis and complications. The sequencial events are as follows.
PANCREATIC ACINAR INJURY
Pancreatic duct obstruction and bile reflux
Gallstone incarcerated in the distal common ductor biliary-pancreatic duct common pathway initiates bilereflux, activates pancreatic trypsin, produces acinar injury which is the traditional viewpoint, but is unexplainable in case when biliary and pancreatic ducts open into the duodenum individually and in those so called idiopathic acute pancreatitis. It had been found that 91% of such cases had microlithiasis or biliary sludge as the cause of transient incarceration. In animal experiments, ligation of pancreatic duct can also induce acute pancreatitis without having bile reflux, showing that pancreatic duct obstruction is also an important pathogenetic factor. Such microlithiasis could not be disclosed by the conventional cholecystography, but could be shown from the bile taken from the recovered patients. After centrifuged and observed under microscope, clustered cholesterol crystals, bilirubin and calcium bicarbonate microgranules were found in 67% of cases. Many recurrent pancreatitis patients when followed up by ultrasound for 12 months, there were cholesterol crystals and microlithiasis, the biliary sludge and microlithiasis could also be seen in the gallbladder specimens, indicating there had been pancreatic obstruction. Pancreatic obstruction caused impedance of pancreatic fluid outflow resulted in elevation of pancreatic pressure and produced pancreatic acinar injury.
High fat, high protein diet
High fat and high aminoacid content in the duodenum can stimulate cholecystokinin (CCK) release, which promotes the acini to secrete enzymes. The zymogen granules located at the fusion of the apical cell membrane dislocate and scatter throughout the cell cytoplasm after stimulation. At this stage, the cells show vacuolation because the zymogen granules have been exocytosed. Alcohol can also sensitize the acini to CCK, activate the intracellular and intraluminal pancreatic enzymes, and initiate the catabolism of intracellular protein under the condition of low pH and ionic changes. Two mechanisms have been proposed to account for the intracellular activation of trypsinogen and the zymogen cascade: trypsinogen autoactivation and trypsinogen activation by the lysosomal enzyme cathepsin B. These are the earliest changes in acute pancreatitis, then activated trypsin again activates other pancreatic enzymes, including pancreatic lipase, amylase, chymotrypsin, phospholipase A2 (PLA2), elastase, carboxylase, nucleotidase, etc. which induce autodigestion of the pancreas. In animal experiments, administering CCK or CCK analogue i.e., cerulein into ligated pancreatic duct, can induce edematous pancreatitis; and injecting taurocholic acid into ligated pancreatic duct can cause necrotizing pancreatitis.
Alcohol has deleterious effects on both pancreatic acini and Oddi’s sphincter. ① It stimulates gastrin secretion and via the cholinergic pathway to stimulate pancreatic secretion, simultaneously, it can cause spasm of Oddi’s sphincter, the two in combination can lead to pancreatitis. ② Alcohol may change the composition of proteins secreted by the pancreas, resulting in the formation of protein plugs within small pancreatic ductules, this insoluble protein is formerly called stone protein. ③ It increases the amount of lysosomal enzymes and increases trypsinogen/ pancreatic trypsinogen inhibitor ratio. ④ Ethanol can change systemic and pancreatic lipid metabolism with accumulation of lipid droplets within the acinar cells, alter membrane fluidity and integrity. ⑤ Ethanol even sensitizes the acinar cells to CCK-stimulated intracellular zymogen proteolysis. In presence of combined-stimulation of CCK and alcohol, it is easier to induce acut e pancreatitis.
Ischemia, decreased perfusion
Transient ischemia enhances enzymatic degradation of acinar cells which become more vulnerable. Hypotension during bypass surgery, pancreatic atherosclerosis with hyperfunction of sympathetic nervous system in the elderly, in combination with the above factors can result in acute pancreatitis with necrosis. Animal experiments on ligation of pancreatic duct and injecting cerulein or taurocholic acid, with additional clamping of upstream of pancreatic artery, that is the celiac artery and superior mesenteric artery for 40 min, can cause pancreatic necrosis, edema and inflammation.
Based on the above facts, severe acute pancreatitis can be induced by a combination of multifactors, which include pancreatic obstruction with or without bile reflux, high fat, high protein diet (hyperstimulation of CCK), alcohol, and ischemia, this is what we encounter in our clinical practice, these factors interact with one another and result in this disease.
CHANGES AFTER ACINAR INJURY
Activation and release of pancreatic enzymes
Activated trypsin again activates other pancreatic enzymes, among which, chymotrypsin promotes hydrolysis of tryptophan, tyrosine and phenylalanine peptide chain; elastase hydrolyzes elastic fibers of extracellular matrix, promotes spreading of protein degradation; carboxypeptidase A and B and RANase, each acts on the components of pancreatic tissue; pancreatic lipase hydrolyzes the lipids, triglyceride, produces free fatty acid which is toxic to the capillaries, leads to lipoperoxidation; and PLA2 hydrolyzes phospholipids including cephalin, sphingo-phospholipids and lysocephalin, destroys structural phospholipid and microvasc ulature, activates platelet activating factor and increases vascular permeability and ischemia. The kaillikren-kinin system produces bradykinin whic h dilates the blood vessel, increases vascular permeability and produces hypotension, these are the earliest events occurring in acute pancreatitis. It had been found that injection of ascitic fluid containing high concentration of bradykinin to healthy animal produces hypotension. But by giving bradykinin antagonist, HOE 140, the pancreatic edema caused by bradykinin can be reduced. The above pancreatic enzymes not only induce autodigestion of pancreas, inflammation of peripancreatic fat, but also circulate in the blood together with the activated cytokines to the remote organs including the lung and brain causing damages. Besides, the release of pancreatic enzymes also activate complement system and thrombo-fibrinolytic system, producing thrombosis in the microvessels. In the ascitic fluid of severe acute pancreatitis patients, activated protease, prospholipase A2, bradykinin, complement component, histamine and some infla mmatory mediators as platelet activating factor (PAF) and prostaglandin are found.
Release of cytokines
During pancreatic necrosis and inflammation, IL-1β, IL-6, TNF-α-mRNA expression can be detected in the pancreas. The macrophages release IL-1, IL-6, TNF-α and IL-8, among which, IL-6 produces acute phase proteins, IL-8 chemotacts neutrophils to the inflamed areas, including the pancreas and the lung. The macrophages are the sources of proinflammatory cytokines (IL-1, IL-6, TNF-α ) and anti-inflammatory cytokines (IL-4, IL-10, IL-1 ra), IL-1 rais IL-1 receptor antagonist, the IL-6 produced in severe acute pancreatitis is greater in amount than that produced in mild acute pancreatitis, and also persists longer. These proinflammatory cytokines induce intercellular adhesive molecules (ICAM 1) and vascular adhesive molecules (VCAM) expression, promote the spread of inflammation , also augment the elastase of neutrophils to produce free radicals damaging the endothelial cells, causing endothelial swelling, and circulatory stasis. In severe acute pancreatitis, increase of proinflammatory cytokines and de crease of anti-inflammatory cytokines are crucial factors in its progression, experimental study revealed that using TNF-α monoclonal antibody or recombinant IL-10, either of them could reduce the severity of the disease and increase the survival rates[11-14].
PAF is the structural component of membrane lipid, it can be synthesized by endothelial cells, macrophages and platelets, and activated by PLA2, producing chemotaxis, aggregation, releasing superoxides, initiating the interaction of neutrophils and endothelial cells and favoring the entrance of neutrophils into the tissue space. It also causes increased vascular permeability of the capillary network of the lung, kidney, heart and the GI tract. Moreover, it enhances the tissue damage by the endotoxin liposaccharide, thus playing a crucial role in the pathogenesis of severe acute pancreatitis, it not only has autocrine and paracrine function, with high content it also has endocrine function, producing multiorgan dysfunction syndrome (MODS). In cerulein and taurocho licacid experimental models, its concentration is increased in the blood, ascitic fluid, pancreas, and lung tissue, producing pancreatic ischemia and increasing the inflammatory cellular infiltration. Recently it is claimed by using PAF antagonist, Lexipafant could decrease vascular permeability, diminish IL-6 and IL-8, and decrease the severity of ARDS, and turn the blood amylase and lipase to normal. In neutropenic patients or using neutrophilic cell antibody, the inflammation in the lungs could be attenuated. 5-fluorouracil formerly used in the treatment of severe acute pancreatitis acted mainly via its upregulating effect of cytokine IL-4 and IL-10.
Increased vascular permeability and Pancreatic microcirculatory impairment
During early stage of acute pancreatitis, the arterioles in the pancreatic lobules constrict, with stasis of neutrophils in the postcapillary venules, in addition, there is increased vascular permeability, these further decrease the pancreatic perfusion. Ischemia causes Ca2+ ion influx, aggravating rupture of lysosomal membrane and release of lysosomal enzymes. On the otherhand, there is increase of TXB2 and TXB2/PGI2 imbalance which constricts further the vessels and endothelin liberated by the damaged endothelium also decreases pancreatic blood flow. The release of TNF-α also promotes vascular permeability, enhances platelet aggregation, stimulates excessive production of nitric oxide. The vessels in the region dilate, hence, the overall effect is the decrease of pancreatic vascular perfusion and blood stasis in the venular net work, leading to local intravascular coagulation. One can see fibrin deposition in the pancreatic capillaries under microscope, the interstitial pressure become s elevated, the red blood cells migrate outward to extravascular space, contributing to the hemorrhage, ischemia, necrosis, inflammation and edema. But the degree of edema is milder in the severe form. Not only is such in the pancreas substance, similar changes also occur in the pulmonary alveoli, the type II alveolar cells can be destroyed resulting in loss of pulmonary surfactant. Low molecular weight dextran and Dan Shen (Salvia Miltiorrhiza) liquid can improve the microcirculation and prevent pancreatic necrosis and lung changes.
Infection-the second attack
In severe acute pancreatitis patients, the cellular immunologic function is compromised, and the CD4+ and CD8+ lymphocytes are markedly diminished, but their ratio remains unchanged, which is quite different from that seen in mild acute pancreatitis. Furthermore, because of increased vascular permeability due to PAF, there is loss of gastrointestinal epithelial barrier function, the gut bacteria translocate from the colon to mesenteric lymph node, peritoneal cavity and blood circulation, IL-6 and IL-8 are further released by endotoxin, TNF-α and IL-1 induction, IL-8 chemotacts and a ttracts more neutrophils a cumulating at the pancreas, lung and other vital organs and tissues. Because of the insufficient endogenous superoxide dismutase, the deletion of glutathione, and presence of various oxygen free radicals destroy the cellular membrane, plasmalemma and the organelles. Procoagulating factors are released leading to cascade of thrombo-fibrinolytic reaction, and produce inflamm atory mediaters from eicosanoid products. Moreover, the neutrophilic elastase is more destructive, causing multiorgan failure. Experimental studies showed that plasma neutrophilic elastase level parallelled the multiple organ failure in severe acute pancreatitis which were positively correlated. This is the so-called second attack theory.
Serious complications of severe acute pancreatitis are mainly adult respiratory distress syndrome (ARDS), disseminated intravascular coagulation (DIC), infected necrosis and pancreatic encephalopathy, their pathogenesis are described as follows (Table 1).
Table 1 Complications of severe acute pancreatitis and their mechan isms.
1. Local complication
Intra and retro-peritoneal fluid collections
Bradykinin, TNF-α, PAF increase vascular permeability with fluid exudation
Unabsorbed fluid collection for long duration
Pancreatic fistula, transient
Pancreatic duct rupture, communicating with pse udocyst
2. Systemic complications
Hypotension, hypovolemic shock
Increased vascular permeability, profuse exudation into peritoneal cavity
Intestinal ileus, dehydration,
Peritonitis; loss of peristaltic function; large quantity of digestive fluid sequestrated
in intestinal lumen; infusion of large volume of crystaloid solution
Formation of calcium soap plaques with fats on peritoneum and mesentery
Hypotension, low blood volume, decrease of renal blood flow
(PAF further decreases renal blood flow)
Acute gastric mucosal bleeding
Pancreatic head edema in mild jaundice, choledocholithiasis in severe jaundice cases
Interstitial lung edema, ARDS
PLA2 destroys structural phospholipid; PAF and TNF-α increase vascular
permeability; Neutrophils release elastase and free radicals damage type I & II lung
epithelial cells with disability of producing surfactants, alveolar atrophy and
Shock, hypercoagulable state; microcirculatory stasis; imbalance of thrombo-
fibrinolytic system; deletion of antithrombin III
PLA2 damages structural phospholipid of brain cell membrane; PAF increases
intracerebral vascular permeability with brain edema and demyelinization of grey
and white matter
Retinal ischemia; white cell emboli with exudation, incre ased vascular permeability
Infection, bacteremia, sepsis
Gut barrier dysfunction with translocation of gut bacteria and endotoxemia, bacteremia
Cellular immunity decreases, sepsis
Same as above, hemodynamic changes caused by inflammatory cytokines and
Underlying ischemic heart disease; overloading of circulation by massive infusion or
too rapid intravenous dripping
Interstitial pulmonary edema and ARDS are caused by many factors: ① phospholipase A2 arrives at the lung by way of circulation, and destroys the type II alveolar cells, which are then unable to produce surfactant; ② the macrophages become vasuolated simultaneously, being unable to phagotyze and digest the protease and clear away the fibrin; ③ neutrophils being chemotacted and accumulated in the lungs, release the destructive elastase and oxygen free radicals; ④ PAF activated by PLA2 can damage the endothelium and increase the vascular permeability, causing ischemia, interstitial pulmonary edema and ARDS. If properly treated, this complication is now rarely seen.
DIC is often due to massive exudation in the peritoneal cavity and retroperitoneal space, hypoalbuminemia and hypovolemic shock, if colloid has not been instituted instantly, hypercoagulation might appear and followed by increased hematocrit, microcirculatory stasis and imbalance of thrombo-fibrinolysis. By given the author’s treatment regime, this complication has not been seen in recent years.
Pancreatic encephalopathy is primarily due to the demyelinization of the cerebral grey and white matter caused by PLA2, which can induce increased vascular permeability, the intravascular osmotic pressure decreases and the brain becomes more vulnerable to transudation, resulting in brain edema. With proper treatment, the recovery in patients aged below 40 is uneventful, those older than 60 especially those with previous history of cerebral infarction may have some sequela.
Infected necrosis and pancreatic abscess. The former usually occurs two weeks after the onset of the disease, the latter occurs four to five weeks after the onset. The invading bacteria usually derive from one’s own GI tract, including the bacilli and cocci. The first five bacteria are B. Coli, Klebsiela, Enterobacillus, Streptococcus faecalis and other Streptococci, there can also be Staphylococcus, Pseudomonas aeruginosa or Bacteroid fragilis. E. coli usually derives from the colon, biliary tract, urinary tract or respiratory tract through hematogenous route, Staphylococcus epidermis bacteremia comes from venous catheterization or urinary catheterization. Pancreatic abscess rarely contains necrotic tissue, but frequently is composed of pure pus. If preventive measures are taken beforehand, sepsis and septicemia can be prevented and are now rarely seen.
Edited by Ma JY
Lerch MM, Saluja AK, Rünzi M, Dawra R, Saluja M, Steer ML. Pancreatic duct obstruction triggers acute necrotizing pancreatitis in the opossum.Gastroenterology. 1993;104:853-861.
Ros E, Navarro S, Bru C, Garcia-Pugés A, Valderrama R. Occult microlithiasis in 'idiopathic' acute pancreatitis: prevention of relapses by cholecystectomy or ursodeoxycholic acid therapy.Gastroenterology. 1991;101:1701-1709.
Lee SP, Nicholls JF, Park HZ. Biliary sludge as a cause of acute pancreatitis.N Engl J Med. 1992;326:589-593.
Yamada T. Textbook of Gastroenterology.2nd Edn, Vol 2, Philadelphia: JB Lippincott. 1995;2065-2071.
Siech M, Weber H, Letko G, Dummler W, Schoenberg MH, Beger HG. Similar morphological and intracellular biochemical changes in alcoholic acute pancreatitis and ischemic acute pancreatitis in rats.Pancreas. 1997;14:32-38.
Shimizu I, Wada S, Okahisa T, Kamamura M, Yano M, Kodaira T, Nishino T, Shima K, Ito S. Radioimmunoreactive plasma bradykinin levels and histological changes during the course of cerulein-induced pancreatitis in rats.Pancreas. 1993;8:220-225.
Satake K, Ha SS, Hiura A. Effects of bradykinin receptor antagonist on the release of beta-endorphin and bradykinin and on hemodynamic changes in a canine model of experimental acute pancreatitis.Pancreas. 1996;12:92-97.
Kusske AM, Rongione AJ, Reber HA. Cytokines and acute pancreatitis.Gastroenterology. 1996;110:639-642.
de Beaux AC, Ross JA, Maingay JP, Fearon KC, Carter DC. Proinflammatory cytokine release by peripheral blood mononuclear cells from patients with acute pancreatitis.Br J Surg. 1996;83:1071-1075.
Kingsnorth A. Role of cytokines and their inhibitors in acute pancreatitis.Gut. 1997;40:1-4.
Hughes CB, Grewal HP, Gaber LW, Kotb M, El-din AB, Mann L, Gaber AO. Anti-TNFalpha therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat.Am J Surg. 1996;171:274-280.
Kusske AM, Rongione AJ, Ashley SW, McFadden DW, Reber HA. Interleukin-10 prevents death in lethal necrotizing pancreatitis in mice.Surgery. 1996;120:284-288; discussion 289.
Pezzilli R, Billi P, Miniero R, Barakat B. Serum interleukin-10 in human acute pancreatitis.Dig Dis Sci. 1997;42:1469-1472.
Ais G, López-Farre A, Gomez-Garre DN, Novo C, Romeo JM, Braquet P, López-Novoa JM. Role of platelet-activating factor in hemodynamic derangements in an acute rodent pancreatic model.Gastroenterology. 1992;102:181-187.
Inoue S, Nakao A, Kishimoto W, Murakami H, Itoh K, Itoh T, Harada A, Nonami T, Takagi H. Anti-neutrophil antibody attenuates the severity of acute lung injury in rats with experimental acute pancreatitis.Arch Surg. 1995;130:93-98.
Kawatsu M, Yamashita T, Ishizuka M, Takeuchi T. Modulation by conagenin of inflammatory mediator productions in mice given 5-fluorouracil.Anticancer Res. 1997;17:917-922.
Klar E, Messmer K, Warshaw AL, Herfarth C. Pancreatic ischaemia in experimental acute pancreatitis: mechanism, significance and therapy.Br J Surg. 1990;77:1205-1210.
Zheng SS, Wei QJ, Wu HG. Study of the protective effect on early lung injury in canine acute necrotizing pancreatitis by Dan Shan (Salvia miltiorrhiza) and Anidosamine.J Integrated Chin Western Med. 1989;9:158-160 (in Chinese).
Widdison AL, Cunningham S. Immune function early in acute pancreatitis.Br J Surg. 1996;83:633-636.
Andersson R, Wang X, Sun Z, Deng X, Soltesz V, Ihse I. Effect of a platelet-activating factor antagonist on pancreatitis-associated gut barrier dysfunction in rats.Pancreas. 1998;17:107-119.
Rinderknecht H. Fatal pancreatitis, a consequence of excessive leukocyte stimulation.Int J Pancreatol. 1988;3:105-112.
Ogawa M. Acute pancreatitis and cytokines: "second attack" by septic complication leads to organ failure.Pancreas. 1998;16:312-315.
Wu XN. The mechanism of actions of Octreotide, Bupleurum-Peony Cheng Qi decoction and Dan Shan in severe acute pancretitis.World J Gastroenterol. 1999;5:249-251.
Robbins EG, Stollman NH, Bierman P, Grauer L, Barkin JS. Pancreatic fungal infections: a case report and review of the literature.Pancreas. 1996;12:308-312.